TEN-YEAR OUTCOMES OF TIPS FOR BUDD-CHIARI SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS

Author:

MORENO Mariana Oliveira Amarante1ORCID,PAZ Cláudio Luiz da Silva Lima2ORCID,DEZAN Maria Gabriela Fernandes3ORCID,CAVALCANTE Lourianne Nascimento4ORCID,LYRA Andre Castro4ORCID

Affiliation:

1. Escola Bahiana de Medicina e Saúde Pública, Brasil

2. Universidade Federal da Bahia, Brasil

3. Escola Bahiana de Medicina e Saúde Pública, Brasil; Hospital São Rafael, Brasil; Universidade Federal da Bahia, Brasil

4. Hospital São Rafael, Brasil; Universidade Federal da Bahia, Brasil; Hospital Universitário Professor Edgard Santos, Brasil

Abstract

ABSTRACT Background: Budd-Chiari syndrome (BCS) results from the obstruction of the hepatic venous flow, usually at the level of the hepatic vein or inferior vena cava. When left untreated, it can progress with several complications, including liver cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) appears to be effective in a subgroup of BCS patients. Objective: To perform a systematic review and meta-analysis of TIPS effectiveness in BCS treatment, considering the survival rate, reduction in portosystemic pressure, need for liver transplantation, technical failure, and shunt dysfunction for up to 10 years of follow-up. Methods: We evaluated 17 studies published in PubMed, Science Direct, Web of Science, and SCOPUS databases, which used TIPS as a treatment for BCS, comprising 618 subjects between 18 and 78 years old. We assessed the bias risk by the NOS, NHI, and JBI scales for cohort studies, before-after studies, and case series, respectively. We conducted the meta-analyses by extracting the number of events and the total patients evaluated to perform the proportion meta-analyses using the R software (“meta” package - version 4.9-6). Results: The pooled results (95%CI) showed a 19% (25.9-12.5%) rate of portosystemic pressure reduction, 6% (1-12%) rate for the need for liver transplants despite the use of TIPS, 2% (1-6%) technical failure rate, 30% (18-46%) shunt dysfunction rate, and 88% (81-93%) for the mean frequency of patients alive between 1 and 10 years after the procedure. We stratified survival rate and found an 86% (74-93%) prevalence of living subjects during less than five years, 92% (83-97%) at five years, and a 77% frequency (68-83%) of patients alive ten years after the TIPS placement. Conclusion: TIPS is an effective treatment for BCS, providing a high 10-year frequency of living patients and a significant decrease in portosystemic pressure. The need for liver transplants after TIPS and the technical failure rate is low.

Publisher

FapUNIFESP (SciELO)

Reference37 articles.

1. Budd - Chiari syndrome: a review by an expert panel;Janssen HLA;J Hepatol,2003

2. Budd-Chiari syndrome-various etiologies and imagistic findings. A pictorial review;Iliescu L;Med Ultrason,2019

3. Orphanet: Síndrome de Budd Chiari,2008

4. Budd-Chiari Syndrome;Lie Plessier A

5. Budd-Chiari Syndrome;Grus T;Prague Med Rep,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3